Neurology page
Wednesday, April 18, 2012
Progressive Multifocal leukoencephalopathy (PML)
PML continues be a nemesis for the antibody based therapies. The new CD30 antibody, Brentuximab, has been associated with PML.
http://www.ncbi.nlm.nih.gov/pubmed/22472351
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)
